A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes

NCT00517283 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: exenatide and placebo
DRUG: Exenatide and placebo
DRUG: Exenatide and placebo

Sponsor

AstraZeneca

Collaborators

[object Object]